Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Pharm Pharmacol ; 70(7): 874-882, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29633269

RESUMEN

OBJECTIVES: Squamous cell carcinoma (SCC) is a malignant disease that affects the oral cavity. Lidocaine has shown antiproliferative and cytotoxic activity on several cell types. The rapid dispersion is a limitation issue; however, the complexation in cyclodextrin improved pharmacological features and modified the drug release. This study investigated the effects of lidocaine (lido) complexed with 2-hydroxypropyl-ß-cyclodextrin (HP-ß-CD-lido) on cell viability and proliferation of human tongue squamous cell carcinoma SCC9 and SCC25. METHODS: The complex formation was confirmed by differential scanning calorimetry (DSC) and scanning electron microscopy (SEM). Cells SCC9 and SCC25 were exposed to lido and HP-ß-CD-lido (40-4000 µm), and the effects on cell viability (MTT) and antiproliferative activity (SRB) were tested. KEY FINDINGS: Differential scanning calorimetry and SEM results demonstrated the occurrence of host-guest interaction. Lido and HP-ß-CD-lido (4000 µm) significantly reduced the viability of SCC9 cells to 83% and 63%, respectively. The viability of SCC25 treated with lido, and HP-ß-CD-lido (4000 µm) was 71% and 44%, respectively. Lido (4000 µm) reduced the proliferation of SCC9 and SCC25 to 39.5% and 23.7%, respectively. HP-ß-CD-lido (4000 µm) was cytotoxic for both cell lines. CONCLUSIONS: HP-ß-CD was able to potentiate the in vitro cytotoxic effects of lidocaine on human squamous cell carcinoma.


Asunto(s)
2-Hidroxipropil-beta-Ciclodextrina/química , Carcinoma de Células Escamosas/patología , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Lidocaína/farmacología , Neoplasias de la Boca/patología , Línea Celular Tumoral , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/química , Humanos , Lidocaína/administración & dosificación , Lidocaína/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...